Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
FoxAI helps inform
References are illustrative of the research literature surrounding this compound
A Phase IIb trial of mRNA-4157 in combination with pembrolizumab for patients with resected high-risk melanoma showed that this combination therapy prolonged recurrence-free survival compared with pembrolizumab monotherapy and had a manageable safety profile
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study [PMID: 32548700] Laboratory literature summary: IGF-1 and cardiometabolic diseases: a Mendelian randomisation study
Grapeseed Extract (250mg): Provides powerful antioxidant protection and supports even skin tone
(1992) characterized the binding kinetics of Long R3 IGF-1, establishing its reduced IGFBP affinity profile
US$ 20.07
US$ 22.22
US$ 22.08
US$ 25.06
